Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for sleep deprivation and ICU delirium in critically ill ventilated patients
ACTRN12620000661976Phase 2Terminated
- Sponsor
- The University of Queensland
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of melatonin in delirium and sleep deprivation (2 arms), sponsored by The University of Queensland. Primary endpoints: Number of sleep arousals and Length of REM sleep phase. Started Dec 2009; status: terminated.
02
Drugs
melatonin
03
Conditions
deliriumsleep deprivation
Beyond the preview
Go deeper on ACTRN12620000661976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620000661976.